Parkside Financial Bank & Trust grew its stake in shares of Xilinx, Inc. (NASDAQ:XLNX) by 9.5% during the third quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,355 shares of the programmable devices maker’s stock after buying an additional 117 shares during the quarter. Parkside Financial Bank & Trust’s holdings in Xilinx were worth $130,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently bought and sold shares of XLNX. Krane Funds Advisors LLC acquired a new position in shares of Xilinx during the second quarter worth $29,000. Citizens Financial Group Inc RI lifted its holdings in Xilinx by 114.2% in the second quarter. Citizens Financial Group Inc RI now owns 257 shares of the programmable devices maker’s stock valued at $30,000 after buying an additional 137 shares during the period. Lenox Wealth Advisors LLC acquired a new position in Xilinx in the second quarter valued at $33,000. FinTrust Capital Advisors LLC lifted its holdings in Xilinx by 168.0% in the second quarter. FinTrust Capital Advisors LLC now owns 276 shares of the programmable devices maker’s stock valued at $33,000 after buying an additional 173 shares during the period. Finally, Quest Capital Management Inc. ADV acquired a new position in Xilinx in the third quarter valued at $38,000. 85.00% of the stock is currently owned by hedge funds and other institutional investors.
XLNX has been the topic of several recent analyst reports. Morgan Stanley dropped their target price on shares of Xilinx from $134.00 to $118.00 and set an “overweight” rating on the stock in a report on Thursday, October 24th. Cascend Securities raised shares of Xilinx from a “hold” rating to a “buy” rating and set a $115.00 price target for the company in a research note on Tuesday, October 22nd. Robert W. Baird decreased their price target on shares of Xilinx from $128.00 to $110.00 and set an “outperform” rating for the company in a research note on Monday, September 23rd. Bank of America downgraded shares of Xilinx from a “buy” rating to a “neutral” rating in a research note on Friday, September 20th. Finally, Rosenblatt Securities reaffirmed a “buy” rating and issued a $165.00 price target on shares of Xilinx in a research note on Tuesday, October 1st. One research analyst has rated the stock with a sell rating, thirteen have assigned a hold rating and thirteen have issued a buy rating to the stock. The stock has an average rating of “Hold” and a consensus target price of $113.26.
Xilinx (NASDAQ:XLNX) last released its earnings results on Wednesday, October 23rd. The programmable devices maker reported $0.94 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.92 by $0.02. The firm had revenue of $833.00 million for the quarter, compared to analysts’ expectations of $823.63 million. Xilinx had a net margin of 28.76% and a return on equity of 35.84%. The company’s quarterly revenue was up 11.7% on a year-over-year basis. During the same period in the previous year, the company earned $0.84 earnings per share. On average, research analysts anticipate that Xilinx, Inc. will post 3.35 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 3rd. Shareholders of record on Tuesday, November 12th will be paid a $0.37 dividend. This represents a $1.48 dividend on an annualized basis and a yield of 1.55%. The ex-dividend date is Friday, November 8th. Xilinx’s payout ratio is 42.53%.
Xilinx announced that its Board of Directors has approved a share buyback plan on Wednesday, October 23rd that allows the company to buyback $1.00 billion in outstanding shares. This buyback authorization allows the programmable devices maker to purchase up to 4.1% of its stock through open market purchases. Stock buyback plans are generally a sign that the company’s management believes its stock is undervalued.
In related news, SVP Emre Onder sold 1,337 shares of the company’s stock in a transaction that occurred on Wednesday, October 16th. The shares were sold at an average price of $96.79, for a total transaction of $129,408.23. Following the sale, the senior vice president now directly owns 4,340 shares in the company, valued at approximately $420,068.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Marshall C. Turner sold 3,000 shares of the company’s stock in a transaction that occurred on Monday, August 19th. The shares were sold at an average price of $107.82, for a total transaction of $323,460.00. Following the sale, the director now owns 44,690 shares in the company, valued at $4,818,475.80. The disclosure for this sale can be found here. Over the last quarter, insiders sold 22,226 shares of company stock worth $2,270,378. Corporate insiders own 0.19% of the company’s stock.
Xilinx Company Profile
Xilinx, Inc designs and develops programmable devices and associated technologies worldwide. Its programmable devices comprise integrated circuits (ICs) in the form of programmable logic devices (PLDs), such as programmable system on chips, and three dimensional ICs; adaptive compute acceleration platform; software design tools to program the PLDs; software development environments and embedded platforms; targeted reference designs; printed circuit boards; and intellectual property (IP) core licenses covering Ethernet, memory controllers, Interlaken, and peripheral component interconnect express interfaces, as well as domain-specific IP in the areas of embedded, digital signal processing and connectivity, and market-specific IP cores.
Featured Article: What is the QQQ ETF?
Want to see what other hedge funds are holding XLNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xilinx, Inc. (NASDAQ:XLNX).
Receive News & Ratings for Xilinx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xilinx and related companies with MarketBeat.com's FREE daily email newsletter.